These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38408137)

  • 1. Therapeutic In Vivo Gene Editing Achieved by a Hypercompact CRISPR-Cas12f1 System Delivered with All-in-One Adeno-Associated Virus.
    Cui T; Cai B; Tian Y; Liu X; Liang C; Gao Q; Li B; Ding Y; Li R; Zhou Q; Li W; Teng F
    Adv Sci (Weinh); 2024 May; 11(19):e2308095. PubMed ID: 38408137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus.
    Kim DY; Lee JM; Moon SB; Chin HJ; Park S; Lim Y; Kim D; Koo T; Ko JH; Kim YS
    Nat Biotechnol; 2022 Jan; 40(1):94-102. PubMed ID: 34475560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.
    Moreno AM; Fu X; Zhu J; Katrekar D; Shih YV; Marlett J; Cabotaje J; Tat J; Naughton J; Lisowski L; Varghese S; Zhang K; Mali P
    Mol Ther; 2018 Jul; 26(7):1818-1827. PubMed ID: 29754775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo CRISPR/Cas9-Mediated Genome Editing Mitigates Photoreceptor Degeneration in a Mouse Model of X-Linked Retinitis Pigmentosa.
    Hu S; Du J; Chen N; Jia R; Zhang J; Liu X; Yang L
    Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):31. PubMed ID: 32330228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR Systems Suitable for Single AAV Vector Delivery.
    Stevanovic M; Piotter E; McClements ME; MacLaren RE
    Curr Gene Ther; 2022; 22(1):1-14. PubMed ID: 34620062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral Delivery of Compact CRISPR-Cas12f for Gene Editing Applications.
    Sharrar A; Meacham Z; Staples-Ager J; Arake de Tacca L; Rabuka D; Collingwood T; Schelle M
    CRISPR J; 2024 Jun; 7(3):150-155. PubMed ID: 38695159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.
    Rasoulinejad SA; Maroufi F
    Mol Biotechnol; 2021 Sep; 63(9):768-779. PubMed ID: 34057656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of AAV Vectors for CRISPR-Mediated In Vivo Genome Editing in the Retina.
    Yu W; Wu Z
    Methods Mol Biol; 2019; 1950():123-139. PubMed ID: 30783971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miniature CRISPR-Cas12f1-Mediated Single-Nucleotide Microbial Genome Editing Using 3'-Truncated sgRNA.
    Lee HJ; Kim HJ; Lee SJ
    CRISPR J; 2023 Feb; 6(1):52-61. PubMed ID: 36576897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing.
    Kong X; Zhang H; Li G; Wang Z; Kong X; Wang L; Xue M; Zhang W; Wang Y; Lin J; Zhou J; Shen X; Wei Y; Zhong N; Bai W; Yuan Y; Shi L; Zhou Y; Yang H
    Nat Commun; 2023 Apr; 14(1):2046. PubMed ID: 37041195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system.
    Zhang Y; Li H; Min YL; Sanchez-Ortiz E; Huang J; Mireault AA; Shelton JM; Kim J; Mammen PPA; Bassel-Duby R; Olson EN
    Sci Adv; 2020 Feb; 6(8):eaay6812. PubMed ID: 32128412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
    El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
    Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Ryr2 Editing Corrects Catecholaminergic Polymorphic Ventricular Tachycardia.
    Pan X; Philippen L; Lahiri SK; Lee C; Park SH; Word TA; Li N; Jarrett KE; Gupta R; Reynolds JO; Lin J; Bao G; Lagor WR; Wehrens XHT
    Circ Res; 2018 Sep; 123(8):953-963. PubMed ID: 30355031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model.
    Patrizi C; Llado M; Benati D; Iodice C; Marrocco E; Guarascio R; Surace EM; Cheetham ME; Auricchio A; Recchia A
    Am J Hum Genet; 2021 Feb; 108(2):295-308. PubMed ID: 33508235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa.
    Bakondi B; Lv W; Lu B; Jones MK; Tsai Y; Kim KJ; Levy R; Akhtar AA; Breunig JJ; Svendsen CN; Wang S
    Mol Ther; 2016 Mar; 24(3):556-63. PubMed ID: 26666451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of CRISPR/Cas9 system by AAV as vectors for gene therapy.
    Wang Y; Jiang H; Li M; Xu Z; Xu H; Chen Y; Chen K; Zheng W; Lin W; Liu Z; Lin Z; Zhang M
    Gene; 2024 Nov; 927():148733. PubMed ID: 38945310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders.
    Kantor B; O'Donovan B; Rittiner J; Hodgson D; Lindner N; Guerrero S; Dong W; Zhang A; Chiba-Falek O
    Nat Commun; 2024 Aug; 15(1):7259. PubMed ID: 39179542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors.
    Wang D; Zhang F; Gao G
    Cell; 2020 Apr; 181(1):136-150. PubMed ID: 32243786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of acquired sensorineural hearing loss in mice by in vivo Htra2 gene editing.
    Gu X; Wang D; Xu Z; Wang J; Guo L; Chai R; Li G; Shu Y; Li H
    Genome Biol; 2021 Mar; 22(1):86. PubMed ID: 33752742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
    Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.